Use this button to switch between dark and light mode.

FDA Controlled Correspondence Checklist

May 09, 2023 (1 min read)

This checklist guides attorneys through drafting and submitting a controlled correspondence to the U.S. Food and Drug Administration (FDA). Controlled correspondence is correspondence submitted to the FDA, by or on behalf of a generic drug manufacturer or related industry, requesting information on a specific element of generic drug product development.

Read now »


Related Content

  • FDA Drug Regulatory Activity Tracker
    Monitor regulatory action items for matters affecting the pharmaceutical industry including effective dates and compliance dates, deadlines for submitting comments in response to FDA proposed rules and draft guidance, and other key information.

Practical Guidance Updates
Featuring the latest updates from your Practical Guidance account.

PRACTICAL GUIDANCE CUSTOMER EMAIL EDITION ON THE WEB

Experience results today with practical guidance, legal research, and data-driven insights—all in one place.

Experience Lexis+